iproniazid has been researched along with Cardiomyopathies in 2 studies
Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| NISSEN, W | 1 |
| ARROYO, H | 1 |
| BERNARD, A | 1 |
2 other studies available for iproniazid and Cardiomyopathies
| Article | Year |
|---|---|
[Myocardial malacia following treatment with iproniazid (marsilid)].
Topics: Cardiomyopathies; Disease; Heart Diseases; Iproniazid; Myocardium | 1959 |
[Apropos of the action of iproniazid on certain metabolic myocardoses].
Topics: Cardanolides; Cardiomyopathies; Heart Diseases; Iproniazid | 1961 |